lessee, summarize the 10Q....
Assets, after amortization, depreciation stuff, about the same.
Liabilities & sharholder equity the same
sales are up a little. Loss is down a little
Cash is up a bit? 51k to 330K (9 months 3/1996 compare to 3/1997)
During the three months ended March 31, 1997 warrants were exercised to purchase 390,000 shares of the Company's common stock for $177,750 consisting of cash of $95,750 and demand notes of $82,000 and the shares were issued.
During the three months ended March 31, 1997 the Company's Board of Directors approved the issuance of 400,000 warrants to acquire 400,000 shares of the Company's common stock at an exercise price of $1.00 which expire January 14, 2000. 350,000 of these warrants were issued to Officers ....
On December 22, 1996, 352,300 shares of the Company's common stock were sold for $299,455($0.85 per share) in a private placement,....
During the three months ended September 30, 1996 the Company's Board of Directors approved the issuance of 1,220,000 warrants to acquire 1,220,000 shares of the Company's common stock at an exercise price of $1.09 which expire July 25, 1999. 560,000 of these warrants were issued to Officers/Directors....
Total revenues increased $33,681 and $67,984 for the three and nine months ended March 31, 1997 as compared to the same periods for 1996 primarily as a result of an increase in revenues of PrimeCare Systems, Inc. ("PSI") and Mooney-Edwards Enterprises, Inc. ("MIS"), subsidiaries of the Company. Cost of sales decreased by $26,627 and increased by $11,228 for the three and nine months ended March 31, 1997, respectively, as compared to the same periods for 1996. The sales of OCG Technology, Inc. ("OCGT"), PSI and MIS were $1,082, $45,071 and $593,050 respectively, for the nine months ended March 31, 1997.
Marketing, general and administrative expenses decreased $27,146 and increased $18,275 for the three and nine months ended March 31, 1997, respectively, as compared to the same periods for 1996. PSI's expense decreased in the three months and nine months ended March 31, 1997, primarily due to the capitalization of $58,183 and $166,885, respectively, of salaries and related costs incurred in the development of the Windows version...
Cash on hand and accounts receivable were $423,142 at March 31, 1997. The Company also has $82,000 of demand notes due from officers/directors related to their exercise of warrants (see Notes to Financial Statements). In addition, the Company has Cardiointegraph equipment, in the final stages of manufacture, which will be available to lease on a fee for service basis. In the past, the Company's principal means of overcoming its cash shortfalls from operations was from the sale of the Company's common stock. During the nine months ended March 31, 1997, the Company raised $672,205 through the sale of equity interests and the exercise of warrants. |